ADAR1 Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
170,598
+91,598
| +116% | +$1.28M | 0.37% | 48 |
|
|
2025
Q1 | $1.06M | Buy |
79,000
+53,000
| +204% | +$714K | 0.2% | 74 |
|
|
2024
Q4 | $498K | Buy |
26,000
+16,794
| +182% | +$322K | 0.1% | 104 |
|
|
2024
Q3 | $209K | Buy |
9,206
+1,206
| +15% | +$27.4K | 0.03% | 151 |
|
|
2024
Q2 | $104K | Buy |
8,000
+5,450
| +214% | +$70.9K | 0.02% | 156 |
|
|
2024
Q1 | $44.7K | Buy |
+2,550
| New | +$44.7K | 0.01% | 169 |
|